Investors

Oncopeptides strives to ensure that analysts, investors, shareholders and financial media are provided with correct information to enhance understanding of our operations.

Webcast - presentation of OCEAN data presented at IMW

Oncopeptides presented data from the OCEAN study at the 18th International Myeloma Workshop (IMW) on September 11. Investors, financial analysts, and media were invited to participate in a webcast including a Q&A on September 12 at 16:00 CEST.

The event was hosted by Marty J Duvall, CEO, Klaas Bakker, CMO as well as Fredrik Schjesvold, MD, Head of Oslo Myeloma Center. The presentation was held in English and was recorded.

More info, presentation and the webcast link

Released

Interim report Q2 2021

Launch dynamics encouraging, but US regulatory situation challenging

CEO Marty J Duvall

 

See the Webcast                     See interview in Di.TV


For further information, please contact:

Linda Holmström
Director of Investor Relations

 

Q3 report November 4, 2021

Profile image

Press release -

Oncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&D

Read press release
Upcoming events

Upcoming events

View calendar

CEO Marty J Duvall summurizes the Year 2020

Our vision is to bring hope to In brief patients through passionate people, innovative science, and transformative medicines.

Released

Annual Report 2020

“The past year was a transformational year for Oncopeptides  highlighted by the FDA´s priority review of our NDA submission, which paved the way for an accelerated approval in the U.S. in early 2021.”

Marty J Duvall, CEO

 

Click here to watch the film where CEO Marty J Duvall summarizes a transformational year.

 

Annual Report 2020 - online version

 

For further information, please contact:

Linda Holmström
Director of Investor Relations

Profile image

Presentations, webcasts and transcripts

See our latest Investor presentations, webcast, transcripts and interviews

To the archive

Oncopeptides via e-mail

Get our latest updates straight to your inbox. Unsubscribe at anytime.

This site is protected by reCAPTCHA & the Google Privacy Policy & Terms of Service  apply.